Naomi S. Sprigg
- Oncology top 2%
- Immunology top 2%
- Molecular Biology
- Pharmacology top 1%
- Cancer Research top 10%
- Co-authors
- Nicos A. NicolaDouglas J. HiltonWarren S. AlexanderDonald MetcalfRobyn StarrSandra E. NicholsonTracy A. WillsonElizabeth M. Viney
- Topics
- Cytokine Signaling Pathways and Interactions (6 papers)interferon and immune responses (3 papers)Immune Cell Function and Interaction (3 papers)
- Cited by
- ImmunologyOncologyPharmacology
- Partner nations
- AustraliaUnited KingdomMalaysia
In The Last Decade
Naomi S. Sprigg
11 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 1.2k
- Immunology 933
- Molecular Biology 546
- Pharmacology 288
- Cancer Research 188
Countries citing papers authored by Naomi S. Sprigg
This map shows the geographic impact of Naomi S. Sprigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi S. Sprigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi S. Sprigg more than expected).
Fields of papers citing papers by Naomi S. Sprigg
This network shows the impact of papers produced by Naomi S. Sprigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi S. Sprigg. The network helps show where Naomi S. Sprigg may publish in the future.
Co-authorship network of co-authors of Naomi S. Sprigg
This figure shows the co-authorship network connecting the top 25 collaborators of Naomi S. Sprigg. A scholar is included among the top collaborators of Naomi S. Sprigg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi S. Sprigg. Naomi S. Sprigg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 49 | |
| 2 | 10 | |
| 3 | 14 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 102 | |
| 7 | 134 | |
| 8 | 78 | |
| 9 | 15 | |
| 10 | SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokinebreakdown → | 635 |
| 11 | Twenty proteins containing a C-terminal SOCS box form five structural classesbreakdown → | 638 |
About Naomi S. Sprigg
Naomi S. Sprigg is a scholar working on Immunology, Oncology and Toxicology, having authored 11 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (6 papers), interferon and immune responses (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (933 citations), Oncology (1.2k citations) and Pharmacology (288 citations). Naomi S. Sprigg has collaborated with scholars based in Australia, United Kingdom and Malaysia. Frequent co-authors include Nicos A. Nicola, Douglas J. Hilton, Warren S. Alexander, Donald Metcalf, Robyn Starr, Sandra E. Nicholson, Tracy A. Willson, Elizabeth M. Viney, Rachael T. Richardson and Paul J. Hertzog. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.